Your email has been successfully added to our mailing list.

×
0 0 0.0103251318101933 0 0.0105448154657293 0.0325131810193321 0.0101054481546572 0.032513181019332
Stock impact report

BioLineRx receives USPTO allowance of new composition of matter patent on motixafortide [Seeking Alpha]

BioLineRx Ltd. - American Depositary Shares (BLRX) 
Last biolinerx ltd. - american depositary shares earnings: 5/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.biolinerx.com
Company Research Source: Seeking Alpha
Patent and Trademark Office for a patent, titled, "COMPOSITION OF BL-8040," which covers the composition of motixafortide (APHEXDA/BL-8040). The patent extends its patent protection on motixafortide in the U.S. through December 2041. Source: Press Release More on BioLineRx BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript Seeking Alpha's Quant Rating on BioLineRx Historical earnings data for BioLineRx Financial information for BioLineRx Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
BLRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BLRX alerts
Opt-in for
BLRX alerts

from News Quantified
Opt-in for
BLRX alerts

from News Quantified